Inventor · disambiguated record
Roberta Cannella
Also filed as: CANNELLA ROBERTA
34 granted patents·6 pending applications·155 citations·filing 2005–2024
97Inventor score
Top patents by PatentIndex Score
40 records- 0197US10828297B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2018·Granted Nov 10, 2020·16 cites·23 claims
- 0294US8426450B1Substituted 4-phenyl pyridines having anti-emetic effectFADINI LUCA·Filed 2012·Granted Apr 23, 2013·22 cites·3 claims
- 0392US8951969B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2013·Granted Feb 10, 2015·7 cites·11 claims
- 0492US8598219B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·8 claims
- 0592US7960424B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted Jun 14, 2011·16 cites·6 claims
- 0692US7947725B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted May 24, 2011·15 cites·2 claims
- 0792US7947724B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2005·Granted May 24, 2011·16 cites·14 claims
- 0891US8729094B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted May 20, 2014·5 cites·30 claims
- 0989US10208073B2Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2018·Granted Feb 19, 2019·2 cites·13 claims
- 1089US9186357B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2013·Granted Nov 17, 2015·4 cites·62 claims
- 1188US9125905B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 8, 2015·2 cites·9 claims
- 1287US8598218B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Dec 3, 2013·6 cites·11 claims
- 1387US8518981B2Liquid pharmaceutical formulations of palonosetronCALDERARI GIORGIO·Filed 2011·Granted Aug 27, 2013·11 cites·12 claims
- 1487US2025235473A1Physiologically balanced injectable formulations of fosnetupitantHELSINN HEALTHCARE SA·Filed 2024·Application pending·0 cites
- 1586US9173942B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Nov 3, 2015·2 cites·19 claims
- 1685US9403772B24-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2012·Granted Aug 2, 2016·4 cites·14 claims
- 1785US8623826B2Compositions and methods for treating centrally mediated nausea and vomitingTRENTO FABIO·Filed 2011·Granted Jan 7, 2014·3 cites·25 claims
- 1884US11529362B2Physiologically balanced injectable formulations of fosnetupitantHELSINN HEALTHCARE SA·Filed 2020·Granted Dec 20, 2022·1 cites·28 claims
- 1983US12208109B2Physiologically balanced injectable formulations of fosnetupitantHELSINN HEALTHCARE SA·Filed 2022·Granted Jan 28, 2025·0 cites·23 claims
- 2083US9066980B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Jun 30, 2015·3 cites·16 claims
- 2182US10624911B2Physiologically balanced injectable formulations of fosnetupitantHELSINN HEALTHCARE SA·Filed 2017·Granted Apr 21, 2020·2 cites·21 claims
- 2279US12071421B2Process for the synthesis of substituted chloromethyl dialkylphosphatesHELSINN HEALTHCARE SA·Filed 2022·Granted Aug 27, 2024·0 cites·3 claims
- 2375US11559523B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2020·Granted Jan 24, 2023·0 cites·18 claims
- 2475US11312698B2Fosnetupitant chloride hydrochloride having improved stabilityHELSINN HEALTHCARE SA·Filed 2020·Granted Apr 26, 2022·0 cites·12 claims
- 2575US9308266B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2013·Granted Apr 12, 2016·1 cites·1 claims
- 2671US10717721B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2018·Granted Jul 21, 2020·0 cites·2 claims
- 2771US9271975B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2013·Granted Mar 1, 2016·0 cites·12 claims
- 2870US2018193262A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2017·Application pending·0 cites
- 2969US9457021B1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Granted Oct 4, 2016·0 cites·20 claims
- 3068US12042494B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2022·Granted Jul 23, 2024·0 cites·18 claims
- 3168US2017042807A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 3267US9908907B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 3367US9439854B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Sep 13, 2016·0 cites·8 claims
- 3466US9943515B2Compositions and methods for treating centrally mediated nausea and vomitingHELSINN HEALTHCARE SA·Filed 2016·Granted Apr 17, 2018·0 cites·23 claims
- 3564US8895586B2Methods of treating emesisFADINI LUCA·Filed 2013·Granted Nov 25, 2014·0 cites·21 claims
- 3664US2014039000A1Liquid pharmaceutical formulations of palonosetronMACCIOCCHI SIMONE·Filed 2013·Application pending·0 cites
- 3762US9457020B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2015·Granted Oct 4, 2016·0 cites·3 claims
- 3862US2016317440A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 3958USD665072SCapsule for pharmaceutical productsTRENTO FABIO·Filed 2011·Granted Aug 7, 2012·11 cites·1 claims
- 4053US2006167072A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roberta Cannella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →